发布求助
文献互助 智能选刊 最新文献

Medical Letter on Drugs and Therapeutics最新文献

筛选
英文 中文
In brief: Subcutaneous ocrelizumab (Ocrevus Zunovo) for multiple sclerosis. 简而言之治疗多发性硬化症的皮下注射奥克雷珠单抗（Ocrevus Zunovo）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714b
{"title":"In brief: Subcutaneous ocrelizumab (Ocrevus Zunovo) for multiple sclerosis.","authors":"","doi":"10.58347/tml.2024.1714b","DOIUrl":"https://doi.org/10.58347/tml.2024.1714b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drugs for hepatitis C virus infection. 治疗丙型肝炎病毒感染的药物。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714a
{"title":"Drugs for hepatitis C virus infection.","authors":"","doi":"10.58347/tml.2024.1714a","DOIUrl":"https://doi.org/10.58347/tml.2024.1714a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Figure 1: Treatment of hepatitis C virus infection in treatment-naive adults. 图 1：治疗未接受治疗的成人丙型肝炎病毒感染。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714e
{"title":"Figure 1: Treatment of hepatitis C virus infection in treatment-naive adults.","authors":"","doi":"10.58347/tml.2024.1714e","DOIUrl":"https://doi.org/10.58347/tml.2024.1714e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Table 3: Some drug interactions with DAAs for HCV infection. 表 3：与治疗 HCV 感染的 DAAs 的一些药物相互作用。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714f
{"title":"Table 3: Some drug interactions with DAAs for HCV infection.","authors":"","doi":"10.58347/tml.2024.1714f","DOIUrl":"https://doi.org/10.58347/tml.2024.1714f","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lazertinib (Lazcluze) for non-small cell lung cancer. 治疗非小细胞肺癌的 Lazertinib（Lazcluze）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714g
{"title":"Lazertinib (Lazcluze) for non-small cell lung cancer.","authors":"","doi":"10.58347/tml.2024.1714g","DOIUrl":"https://doi.org/10.58347/tml.2024.1714g","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addendum: Effectiveness of mRNA COVID-19 vaccines. 增编：mRNA COVID-19 疫苗的有效性。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-14 DOI: 10.58347/tml.2024.1713h
{"title":"Addendum: Effectiveness of mRNA COVID-19 vaccines.","authors":"","doi":"10.58347/tml.2024.1713h","DOIUrl":"10.58347/tml.2024.1713h","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drugs for plaque psoriasis. 治疗斑块状银屑病的药物。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-09-30 DOI: 10.58347/tml.2024.1712a
{"title":"Drugs for plaque psoriasis.","authors":"","doi":"10.58347/tml.2024.1712a","DOIUrl":"10.58347/tml.2024.1712a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142301220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influenza vaccine for 2024-2025. 2024-2025 年流感疫苗。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-09-16 DOI: 10.58347/tml.2024.1711a
{"title":"Influenza vaccine for 2024-2025.","authors":"","doi":"10.58347/tml.2024.1711a","DOIUrl":"https://doi.org/10.58347/tml.2024.1711a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142301216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Roflumilast cream (Zoryve) for atopic dermatitis. 治疗特应性皮炎的罗氟司特乳膏（Zoryve）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-09-16 DOI: 10.58347/tml.2024.1711b
{"title":"Roflumilast cream (Zoryve) for atopic dermatitis.","authors":"","doi":"10.58347/tml.2024.1711b","DOIUrl":"https://doi.org/10.58347/tml.2024.1711b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142301217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 update: New Pfizer and Moderna vaccine formulations for 2024-2025. COVID-19 更新：辉瑞和 Moderna 2024-2025 年新疫苗配方。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-09-16 DOI: 10.58347/tml.2024.1711c
{"title":"COVID-19 update: New Pfizer and Moderna vaccine formulations for 2024-2025.","authors":"","doi":"10.58347/tml.2024.1711c","DOIUrl":"https://doi.org/10.58347/tml.2024.1711c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142301215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信